Notable Intellia Therapeutics Insider Trades $350K In Company Stock

David Lebwohl, EVP And Chief Medical Officer at Intellia Therapeutics NTLA, made a large buy and sell of company shares on November 5, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that David Lebwohl exercised options to purchase 2,400 Intellia Therapeutics shares at a price of $12.62 per share for a total of $30,288 on November 5. They then sold their shares on the same day in the open market. They sold at prices ranging from $131.71 to $135.34 to raise a total of $318,535 from the stock sale.

Following the transaction, Lebwohl still owns 8,714 shares of the company, worth $1,192,510.

Intellia Therapeutics shares are trading down 1.09% at $136.85 at the time of this writing on Wednesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Important Transaction Codes

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Intellia Therapeutics's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.